Nigel Stallard Selected Research

Therapeutics

1/2022	Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
7/2020	RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trial.
7/2020	Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.
11/2018	Recommendations for the design of small population clinical trials.
1/2018	Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
2/2016	Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
10/2007	A study of the efficacy and cost-effectiveness of MRSA screening and monitoring on surgical wards using a new, rapid molecular test (EMMS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nigel Stallard Research Topics

Disease

3	COVID-19 01/2022 - 07/2020
3	Out-of-Hospital Cardiac Arrest 01/2020 - 11/2016
3	Multiple Sclerosis 01/2020 - 02/2016
3	Heart Arrest (Cardiac Arrest) 11/2016 - 10/2011
2	Rotator Cuff Injuries 01/2022 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 07/2020
2	Chronic Progressive Multiple Sclerosis 01/2020 - 01/2018
2	Rare Diseases (Rare Disease) 11/2018 - 07/2017
2	Pain (Aches) 01/2017 - 12/2015
2	Low Back Pain (Lumbago) 01/2017 - 12/2015
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2021
1	Sudden Death 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Obesity 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Disease Progression 01/2018
1	Back Pain (Backache) 01/2017
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 02/2016
1	Neoplasms (Cancer) 02/2016
1	Breast Neoplasms (Breast Cancer) 02/2016
1	Osteoporosis 01/2014
1	Cross Infection (Nosocomial Infection) 10/2007

Drug/Important Bio-Agent (IBA)

3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020 - 11/2016
2	Oxygen (Dioxygen)IBA 01/2022 - 07/2020
2	Neuroprotective AgentsIBA 01/2020 - 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 10/2021
1	Amiloride (Midamor)FDA LinkGeneric 01/2020
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2020
1	Riluzole FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Hormones (Hormone)IBA 02/2016
1	human ERBB2 proteinIBA 02/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2007

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2007
2	Continuous Positive Airway Pressure 01/2022 - 07/2020
2	Conservative Treatment 01/2022 - 01/2017
2	Resuscitation 08/2018 - 10/2011
2	Injections 01/2017 - 12/2015
2	Cardiopulmonary Resuscitation (CPR) 11/2015 - 10/2011
1	Debridement 01/2020
1	Drug Therapy (Chemotherapy) 02/2016
1	Adjuvant Chemotherapy 02/2016
1	Musculoskeletal Manipulations (Manipulative Therapy) 01/2014
1	Resuscitation Orders (Do Not Resuscitate Orders) 10/2011